Page last updated: 2024-10-25

deferoxamine and Infections, Coronavirus

deferoxamine has been researched along with Infections, Coronavirus in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Li, Y2
Bao, Y1
Duan, X1
Dong, S1
Lin, J1
Chang, X1
Tan, Y1
Zhang, H1
Shan, H1
Abobaker, A1

Other Studies

2 other studies available for deferoxamine and Infections, Coronavirus

ArticleYear
RSL3 Inhibits Porcine Epidemic Diarrhea Virus Replication by Activating Ferroptosis.
    Viruses, 2023, 10-12, Volume: 15, Issue:10

    Topics: Acetylcysteine; Animals; Chlorocebus aethiops; Coronavirus Infections; Deferoxamine; Diarrhea; Ferro

2023
Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?
    European journal of clinical pharmacology, 2020, Volume: 76, Issue:11

    Topics: Animals; Anti-Inflammatory Agents; Antibodies, Neutralizing; Antiviral Agents; B-Lymphocytes; Betaco

2020